Related Experiment Videos
The severe long-term outcomes of 'non-severe' eosinophilic granulomatosis with polyangiitis
Alvise Berti1,2
1Department of Rheumatology, Santa Chiara Hospital, University of Trento, Trento, Italy.
Rheumatology (Oxford, England)
|July 2, 2019
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Dual REmission in moderate-to-severe AsthMa and Nasal Polyps: a multicentric observational Phase IV real-life study (DREAM-NP).
Expert opinion on biological therapy·2026
2025 EULAR recommendations for the management of polymyalgia rheumatica and primary large vessel vasculitis.
Annals of the rheumatic diseases·2026
Combined Large and Small Airway Obstruction Is Associated With Increased Exacerbation Frequency and Poorer Symptom Control in Persistent Asthma.
The journal of allergy and clinical immunology. In practice·2026
Small airway dysfunction may mediate the association between body mass index and severe asthma exacerbations.
The European respiratory journal·2026
Dual Remission in Patients with Moderate-to-Severe Asthma and CRSwNP Treated with Dupilumab: A 24-Month Real-World Study.
Journal of clinical medicine·2026
Clinical outcomes of subglottic stenosis in granulomatosis with polyangiitis: results of an international multicentre observational study.
Rheumatology (Oxford, England)·2026
Impacts of socioeconomic status on ambulatory care sensitive condition hospitalizations in rheumatoid arthritis.
Rheumatology (Oxford, England)·2026
Performance of lupus classification criteria in monogenic lupus: a national multicenter cohort study.
Rheumatology (Oxford, England)·2026
Efficacy and safety of probiotic supplementation in psoriatic arthritis - a randomized controlled trial.
Rheumatology (Oxford, England)·2026
Is Trabecular bone score associated with multiple fragility fractures? Evidence from a large observational cohort study.
Rheumatology (Oxford, England)·2026
Ability of SLE-DAS and SLEDAI-2K to predict damage accrual in SLE: A real-world 7-year cohort study from Sweden.
Rheumatology (Oxford, England)·2026